Banning Abortion in Cases of Down Syndrome: Important Lessons for Advances in Genetic Diagnosis
By Rebecca B. Reingold and Lawrence O. Gostin,
JAMA
| 05. 18. 2018
In December 2017, Ohio passed into law legislation that prohibited physicians from performing abortions if the pregnant woman’s decision was influenced by her belief that the fetus has Down syndrome. Physicians who perform abortions in these cases would face fourth-degree felony charges and revocation of their medical license. No other state bans abortion specifically for Down syndrome, but several ban abortions in cases of genetic diseases. Lower courts have struck down most such laws, holding they violate the constitutional rights of women. In February 2018, a federal district court judge blocked enforcement of Ohio’s law pending a final determination.
The Ohio statute raises compelling legal and ethical issues: Will it interfere with the patient-physician relationship and, in turn, the health outcomes of pregnant women and their children? Should women have to justify their reasons for terminating a pregnancy? The disability rights movement has challenged prevailing stereotypes and advocated for greater integration of persons with disabilities into society. Do these kinds of laws promote support for or detract from more inclusive, nondiscriminatory environments?
Down Syndrome: Current State of Knowledge
In the...
Related Articles
By Pete Shanks
| 02.27.2026
Last month, we published “The Shameful Legacy of Tuskegee” which focused on a proposed experiment in Guinea-Bissau. The study’s plan echoed the notorious Tuskegee disaster, withholding safe, effective vaccines against hepatitis B from some newborns while inoculating others. It was to be financed by the U.S. but performed by a controversial Danish team. That project provoked a multi-national outcry, leading to a remarkable response from the World Health Organization:
WHO has significant concerns regarding the study’s scientific...
By Kiana Jackson and Shannon Stubblefield, New Disabled South | 02.09.2026
"MC0_8230" via Wikimedia Commons licensed under CC by 2.0
This report documents a deliberate assault on disabled people in the United States. Not an accident. Not a series of bureaucratic missteps. An assault that has been coordinated across agencies...
By Zachary Brennan, Endpoints News | 02.23.2026
The FDA is spelling out the details of a new pathway to help speed personalized cell and gene therapies to market for rare diseases.
Monday’s long-awaited draft guidance outlines the agency’s “plausible mechanism” framework, a pathway FDA Commissioner Marty Makary...
By Ilyse Hogue, The Bulwark | 02.20.2026
Since I started working to understand the radicalization of young men, I’ve gotten asked the same question everywhere I go: Are they a lost cause for Democrats? Too redpilled to reach? Too far gone to bring back?
My answer has...